A Phase III, Multi-Center, Double-Blind, Placebo-Controlled, Randomized Study of Intravenous L-Citrulline in Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis in Children, Adolescents and Young Adults (6 to 21 Years)
Latest Information Update: 03 Jun 2025
At a glance
- Drugs Citrulline (Primary)
- Indications Vaso-occlusive crisis
- Focus Registrational; Therapeutic Use
- Sponsors Asklepion Pharmaceuticals
Most Recent Events
- 28 May 2025 New trial record